Abordaje integral de las comorbilidades en la EPOC: recomendaciones de expertos

Graphical abstract

• Publication year

  2025

• Venue

  Open Respiratory Archives

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.opresp.2025.100511PMID 41399722PMCID 12702106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.

  2024influential reference
• Comorbidities in COPD: Current and Future Treatment Challenges

  2024cited by this paper
• Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in COPD: A Post-hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS).

  2024cited by this paper
• Exploring the impact of comorbid dementia on exacerbation occurrence in general practice patients with chronic obstructive pulmonary disease

  2024cited by this paper
• Diabetes mellitus with poor glycemic control is a risk factor for pneumonia in COPD.

  2024cited by this paper
• COPD is associated with increased cardiovascular disease risk independent of phenotype

  2024cited by this paper
• Risk of severe cardiovascular events following COPD exacerbations: results from the EXACOS-CV study in Spain.

  2024cited by this paper
• The Role of Inhaled Corticosteroids in Reducing Cardiovascular Risk: Seeing Is Not Always Believing

  2024cited by this paper
• Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study

  2024cited by this paper
• Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Response to Additional Considerations.

  2024cited by this paper
• Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study

  2023cited by this paper
• Impact of Cardiovascular and Metabolic Comorbidities on Long-term Outcomes of Home-based Pulmonary Rehabilitation in COPD

  2023cited by this paper
• Inhaled Corticosteroids and Risk of Cardiovascular Disease in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Regression.

  2023cited by this paper
• Hyperglycaemia and Chronic Obstructive Pulmonary Disease

  2023cited by this paper
• Systematic Review and Meta-Analysis of Psychological Distress and Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Consequences

  2023cited by this paper
• Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

  2023cited by this paper
• Lack of Clinical Control in COPD Patients Depending on the Target and the Therapeutic Option

  2023cited by this paper
• COPD Assessment Test as a Screening Tool for Anxiety and Depression in Stable COPD Patients: A Feasibility Study

  2023cited by this paper
• Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD?

  2022cited by this paper
• Similar Programmed Death Ligand 1 (PD-L1) expression pro�le in patients with mild COPD and lung cancer

  2022cited by this paper
• Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer

  2022cited by this paper
• Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort study

  2022cited by this paper
• Effect of intravenous ferric carboxymaltose on exercise capacity and quality of life in patients with COPD

  2022cited by this paper
• [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.

  2022cited by this paper
• Prescription Patterns in Patients with Chronic Obstructive Pulmonary Disease and Osteoporosis

  2021cited by this paper
• Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial.

  2021cited by this paper
• Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.

  2021influential reference
• The impact of osteoporosis and vertebral compression fractures on mortality and association with pulmonary function in COPD: A meta-analysis.

  2021cited by this paper
• Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis

  2021cited by this paper
• Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus

  2021cited by this paper
• Clinical Control Criteria to Determine Disease Control in Patients with Severe COPD: The CLAVE Study

  2021cited by this paper
• Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.

  2020cited by this paper
• From Mild Cognitive Impairment (MCI) to Dementia in Chronic Obstructive Pulmonary Disease. Implications for Clinical Practice and Disease Management: A Mini-Review

  2020cited by this paper
• Undiagnosed Obstructive Sleep Apnea May Significantly Impact Outcomes in Adults Admitted for COPD in an Inner-City Hospital.

  2020cited by this paper
• The Impact of Depression and Anxiety on Chronic Obstructive Pulmonary Disease Acute Exacerbations: A prospective cohort study.

  2020cited by this paper
• Prevalence and risk factors for osteoporosis in individuals with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

  2019cited by this paper
• Effectiveness of cognitive behavioural therapy for chronic obstructive pulmonary disease patients: A systematic review and meta-analysis.

  2019cited by this paper
• Mortality and vertebral fracture risk associated with long-term oral steroid use in patients with chronic obstructive pulmonary disease: A systemic review and meta-analysis

  2019cited by this paper
• Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

  2019cited by this paper
• Osteoporosis among Patients with Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-analysis of Prevalence, Severity, and Therapeutic Outcomes

  2019cited by this paper
• High prevalence of bronchiectasis in emphysema-predominant COPD patients

  2018cited by this paper
• Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study

  2018cited by this paper
• Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease

  2018cited by this paper
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  2018cited by this paper
• Once‐Daily Single‐Inhaler Triple versus Dual Therapy in Patients with COPD

  2018cited by this paper
• Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study

  2017cited by this paper
• Association of chronic obstructive pulmonary disease with mild cognitive impairment and dementia

  2017cited by this paper
• The impact of cognitive impairment on self-management in chronic obstructive pulmonary disease: A systematic review.

  2017cited by this paper
• Strategies to improve anxiety and depression in patients with COPD: a mental health perspective

  2016cited by this paper
• Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

  2016cited by this paper
• Cognitive function and living situation in COPD: is there a relationship with self-management and quality of life?

  2015cited by this paper
• The impact of corticosteroid treatment on hemoglobin A1C levels among patients with type-2 diabetes with chronic obstructive pulmonary disease exacerbation.

  2014cited by this paper
• The association between co-morbidities and physical performance in people with chronic obstructive pulmonary disease

  2014cited by this paper
• Psychometric properties of the Beck Depression Inventory-II: a comprehensive review.

  2013cited by this paper
• Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis.

  2013cited by this paper
• Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort.

  2011cited by this paper
• A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD.

  2010cited by this paper
• Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome.

  2010cited by this paper
• The Effect of an Inhaled Corticosteroid on Glucose Control in Type 2 Diabetes

  2009cited by this paper
• Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs.

  2009cited by this paper
• Chronic Obstructive Pulmonary Disease Patients With Psychiatric Disorders Are at Greater Risk of Exacerbations

  2009cited by this paper
• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  2005cited by this paper
• Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study.

  2004cited by this paper
• Anxiety and Chronic Obstructive Pulmonary Disease: Prevalence, Impact, and Treatment

  2003cited by this paper
• Global initiative for chronic obstructive lung disease.

  2002cited by this paper
• The validity of the Hospital Anxiety and Depression Scale. An updated literature review.

  2002cited by this paper
• Prevalence, impact, and treatment

  1990cited by this paper
• An inventory for measuring clinical anxiety: psychometric properties.

  1988cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS)

  year unknowncited by this paper

• No citing papers are available for this paper.